Biomarkers are emerging as a potential tool for screening or diagnosing sarcopenia. We
aimed to summarize the current evidence on the diagnostic test accuracy of biomarkers for …

The loss of muscle mass and strength in elderly population (especially after the age of 65–
70) represents a public health problem. Due to the high prevalence of frailty in older adults …

The role of physical activity in improving overall aspects of health regardless of age is well
documented. Due to the coronavirus disease 2019 outbreak, preventive measures to limit …

This extensive review examines sarcopenia, a condition characterized by a loss of muscle
mass, stamina, and physical performance, with a particular emphasis on its detection and …

Objective To summarize recent findings on the association of low skeletal muscle mass and
muscle quality with overall survival and recurrence-free survival in patients with pancreatic …

OBJECTIVE: The aim of this study was to examine the association of sarcopenia and low
muscle attenuation with survival and other clinical outcomes in patients with ovarian cancer …

Simple Summary A growing number of studies have focused their attention on the potential
role of microRNAs (miRNA) as biomarkers for several diseases. However, very few …

Aims The objective of this study is to provide a reliable strategy for the diagnosis of
sarcopenia based on a complementary combination of biomarkers from various approaches …

Sarcopenia is the progressive loss of muscle mass wherein Fyn regulates STAT3 to
decrease autophagy. To elucidate the role of inflammation in Fyn-STAT3-dependent …

Sarcopenia is a multifactorial age-related disorder that causes a decrease in muscle mass,
strength, and function, leading to alteration of movement, risk of falls, and hospitalization …